Tag Archives: Into

Keytruda May Help Put Melanoma Into Remission

TUESDAY, Feb. 26, 2019 (HealthDay News) — For people with the deadly skin cancer melanoma, one dose of the drug Keytruda before surgery might stop the cancer in its tracks, according to a groundbreaking new study. Keytruda (pembrolizumab) is a PD-1 inhibitor, an immunotherapy drug that triggers the body’s immune response to attack cancer cells.… Read More »

Scientists harness machine learning to uncover new insights into the human brain

An inter-disciplinary research team led by scientists from the National University of Singapore (NUS) has successfully employed machine learning to uncover new insights into the cellular architecture of the human brain. The team demonstrated an approach that automatically estimates parameters of the brain using data collected from functional magnetic resonance imaging (fMRI), enabling neuroscientists to… Read More »